Seasonal and perennial allergic conjunctivitis: The possible role of nasal allergy

Clinical and Experimental Ophthalmology

Volumn 37, Issue 5, 2009, Pages 448-457

  Pelikan, Zdenek ^a  

^a Allergy Research Foundation   (Netherlands)

Author keywords

Conjunctival response; Nasal allergy; Nasal challenge with allergen; Perennial allergic conjunctivitis (PAC); Seasonal allergic conjunctivitis (SAC)

Indexed keywords

AGENTS ACTING ON THE EYE; SODIUM CHLORIDE;

ADULT; ALLERGIC RHINITIS; ANAMNESIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE ALLERGY; NOSE PROVOCATION TEST; PERENNIAL ALLERGIC CONJUNCTIVITIS; RHINOMANOMETRY; SEASONAL ALLERGIC CONJUNCTIVITIS; SEASONAL VARIATION; SKIN TEST;

ADOLESCENT; ADULT; ALLERGENS; CONJUNCTIVITIS, ALLERGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL PROVOCATION TESTS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SEASONS; SKIN TESTS;

EID: 67651175963     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2009.02079.x     Document Type: Article

References (59)

1. Bielory L, Friedlaender MH. Allergic conjunctivitis. Immunol Allergy Clin North Am 2008; 28: 43-57.
2. Uchio E, Kimura R, Migita H, Kozawa M, Kadonosono K. Demographic aspects of allergic ocular diseases and evaluation of new criteria for clinical assessment of ocular allergy. Graefes Arch Clin Exp Ophthalmol 2008; 246: 291-6.
3. Bielory L. Ocular allergy overview. Immunol Allergy Clin North Am 2008; 28: 1-23.
4. Dart JK, Buckley RJ, Monnickendan M, Prasad J. Perennial allergic conjunctivitis: Definition, clinical characteristics and prevalence. A comparison with seasonal allergic conjunctivitis. Trans Ophthalmol Sci UK 1986; 105: 513-20.
5. McGill JI, Holgate ST, Church MK, Anderson DF, Bacon A. Allergic eye disease mechanisms. Br J Ophthalmol 1998; 82: 1203-14.
6. Bielory L. Allergic and immunologic disorders of the eye; Part II: ocular allergy. J Allergy Clin Immunol 2000; 106: 1019-32.
7. Ziskin A. Allergic conjunctivitis. Curr Allergy Clin Immunol 2006; 19: 56-9.
8. Barney NP, Graziano FM. Allergic and immunologic diseases of the eye. In: Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FE, eds. Middleton's Allergy, Principles and Practice, 6th edn. Philadelphia: Mosby Inc., 2003; 1599-617.
9. Leonardi A. In-vivo diagnostic measurements of ocular inflammation. Curr Opin Allergy Clin Immunol 2005; 5: 464-72.
10. Radcliffe MJ, Lewith GT, Prescott P, Church MK, Holgate ST. Do skin prick and conjunctival provocation tests predict symptom severity in seasonal allergic rhinoconjunctivitis? Clin Exp Allergy 2006; 36: 1488-93.
11. Ono SA, Abelson MB. Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol 2005; 115: 118-22.
12. Abelson MB, Chambers WA, Smith LM. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol 1990; 108: 84-8.
13. HelintöM, Renkonen R, Tervo T et al. Direct in vivo monitoring of acute allergic reactions in human conjunctiva. J Immunol 2004; 172: 3235-42.
14. Melillo G, Bonini S, Cocco G et al. Provocation tests with allergens. Allergy 1997; 52 (Suppl. 35): 5-36.
15. Bonini S, Bonini S, Berruto A et al. Conjunctival provocation test as a model for the study of allergy and inflammation in humans. Int Arch Allergy Appl Immunol 1989; 88: 144-8.
16. Friedlaender MH. Conjunctival provocation testing: Overview of recent clinical trials in ocular allergy. Int Ophthalmol Clin 2003; 43: 95-104.
17. Bacon AS, Ahluwalia P, Irani AM et al. Tear and conjunctival changes during the allergen-induced early- and late-phase responses. J Allergy Clin Immunol 2000; 106: 948-54.
18. Abelson MB, Loeffler O. Conjunctival allergen challenge: Models in the investigation of ocular allergy. Curr Allergy Asthma Rep 2003; 3: 363-8.
19. Anderson DF. The conjunctival late-phase reaction and allergen provocation in the eye. Clin Exp Allergy 1996; 26: 1105-7.
20. Pelikan M, Pelikan Z. The role of the nasal mucosa in some cases of allergic conjunctivitis and the effects of Disodium Cromoglycate (DSCG). J Allergy Clin Immunol 1985; 75 (1 Suppl.): 186.
21. Pelikan Z. Allergic conjunctivitis: Primary and secondary role of the allergy reaction in the nose. Dutch J Med (Ned Tijdschr Geneesk) 1988; 132: 561-3.
22. Pelikan Z. The causal role of the nasal allergy in some patients with allergic conjunctivitis. Allergy 2002; 57 (Suppl. 73): 230.
23. Pelikan Z. Late nasal response-its clinical characteristics, features, and possible mechanisms. In: Dorsch W, ed. Late Phase Allergic Reactions. Boca Raton, FL, Ann Arbor, MI, Boston, MA: CRC Press, 1990; 111-55.
24. Pelikan Z. The late nasal response. Thesis. The Free University of Amsterdam, Amsterdam, 1996.
25. Pelikan Z, Feenstra L, Barree GOF. Response of the nasal mucosa to allergen challenge measured by two different methods of rhinomanometry. Ann Allergy 1977; 38: 263-7.
26. Pelikan Z. Late and delayed response of the nasal mucosa to allergen challenge. Ann Allergy 1978; 41: 37-47.
27. Potthoff RF, Roy SN. A generalized multivariate analysis of variance model, useful especially for growth curve problems. Biometrica 1964; 51: 313-26.
28. Timm NH. Multivariate Analysis with Application in Educations and Psychology. Monteray, CA: Brooks Cole, 1975.
29. Tabachnick BG, Fidell LS. Using Multivariate Statistics. New York: Harper Collins College Publishers, 1996.
30. Bonini S, Lambiase A, Sachhetti M, Bonini S. Cytokines in ocular allergy. Int Ophthalmol Clin 2003; 43: 27-32.
31. Cook EB. Tear cytokines in acute and chronic ocular allergic inflammation. Curr Opin Allergy Clin Immunol 2004; 4: 441-5.
32. Calder VL, Jolly G, Hingorani M et al. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease. Clin Exp Allergy 1999; 29: 1214-22.
33. Dua HS, Gomes JA, Donoso LA, Laibson PR. The ocular surface as part of the mucosal immune system: Conjunctival mucosa-specific lymphocytes in ocular surface pathology. Eye 1995; 9: 261-7.
34. Calder VL. Cellular mechanisms of chronic cell-mediated allergic conjunctivitis. Clin Exp Allergy 2002; 32: 814-17.
35. Leonardi A, Fregona IA, Plebani M, Secchi AG, Calder VL. Th1- and Th2-type cytokines in chronic ocular allergy. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1240-5.
36. Stahl JL, Barney NP. Ocular allergic disease. Curr Opin Allergy Clin Immunol 2004; 4: 455-9.
37. Pelikan Z. The possible involvement of nasal allergy in allergic keratoconjunctivitis. Eye 2008. doi: 10.1038/eye.2008.341
38. Abelson M, Howes J, George M. The conjunctival provocation test model of ocular allergy: Utility for assessment of an ocular corticosteroid, Loteprednol etabonate. J Ocul Pharmacol Ther 1998; 14: 533-42.
39. Abelson MB, Spitalny L. Combined analysis of two studies using the conjunctival allergen challenge model to evaluate Olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity. Am J Ophthalmol 1998; 125: 797-804.
40. Abelson MB. Evaluation of Olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model. Ann Allergy Asthma Immunol 1998; 81: 211-18.
41. Abelson MB, George MA, Schaefer K, Smith LM. Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine in the clinical allergen challenge model of allergic conjunctivitis. J Allergy Clin Immunol 1994; 94: 458-64.
42. Leonardi A, Curnow SJ, Zhan H, Calder VL. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy 2006; 36: 777-84.
43. Magone MT, Whitcup SM, Fukushima A, Chan CC, Silver PB, Rizzo LV. The role of IL-12 in the induction of late-phase cellular infiltration in a murine model of allergic conjunctivitis. J Allergy Clin Immunol 2000; 105: 299-308.
44. Metz DP, Hingorani M, Calder VL, Buckley RJ, Lightman SL. T-cell cytokines in chronic allergic eye disease. J Allergy Clin Immunol 1997; 100: 817-24.
45. Zoukhri D. Effect of inflammation on lacrimal gland function. Exp Eye Res 2006; 82: 885-98.
46. Baudouin Ch, Liang H, Bremond-Gignac D et al. CCR4 and CCR5 expression in conjunctival specimens as differential markers of TH1/TH2 in ocular surface disorders. J Allergy Clin Immunol 2005; 116: 614-19.
47. Stern ME, Siemasko KF, Niederkorn JY. The Th1/Th2 paradigm in ocular allergy. Curr Opin Allergy Clin Immunol 2005; 5: 446-50.
48. Paulsen F. The human nasolacrimal ducts. Adv Anat Embryol Cell Biol 2003; 170: 1-106.
49. Sirigu P, Maxia C, Puxeddu R, Zucca I, Piras F, Perra MT. The presence of a local immune system in the upper blind and lower part of the human nasolacrimal dust. Arch Histol Cytol 2000; 63: 431-9.
50. Motterle L, Diebold Y, De Salamanca AE et al. Altered expression of neurotransmitter receptors and neuromediators in vernal keratocinjunctivitis. Arch Ophthalmol 2006; 124: 462-8.
51. Calonge M, De Salamanca AE, Siemasko KF et al. Variation in the expression of inflammatory markers and neuroreceptors in human conjunctival epithelial cells. Ocul Surf 2005; 3(4 Suppl.): 145-8.
52. Fujishima H, Takeyama M, Takeuchi T, Saito T, Tsubota K. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Allergy 1997; 27: 372-8.
53. Knop E, Knop N. Lacrimal drainage-associated lymphoid tissue (LDALT): A part of the human mucosal immune system. Invest Ophthalmol Vis Sci 2001; 42: 566-74.
54. Knop N, Knop E. Conjunctiva-associated lymphoid tissue in the human eye. Invest Ophthalmol Vis Sci 2000; 41: 1270-9.
55. Paulsen FP, Paulsen JL, Thale AB, Schaudig U, Tillmann BN. Organized mucosa-associated lymphoid tissue in human nasolacrimal ducts. Adv Exp Med Biol 2002; 506: 873-6.
56. Paulsen FP, Schaudig U, Thale AB. Drainage of tears: Impact on the ocular surface and lacrimal system. Ocul Surf 2003; 1: 180-91.
57. O'Sullivan NL, Montgomery PC, Sullivan DA. Ocular mucosal immunity. In: Mestecky J, Binnenstock J, Lamm M, Strober W, McGhee J, Mayer L, eds. Mucosal Immunology, 3rd edn. Burlington, MA, San Diego, CA, London: Elsevier-Academic Press, 2005; 1477-1496.
58. Mikulowska-Mennis A, Xu B, Berberian JM, Michie SA. Lymphocyte migration to inflamed lacrimal glands is mediated by vascular cell adhesion molecule-1/α4β1 integrin, peripheral node addressin/ L-selectin, and lymphocyte function-associated antigen-1 adhesion pathways. Am J Pathol 2001; 159: 671-81.
59. Youngman KR, Lazarus NH, Butcher EC. Lymphocyte homing: Chemokines and adhesion molecules in T cell and IgA plasma cell localization in the mucosal immune system. In: Mestecky J, Binnenstock J, Lamm M, Strober W, McGhee J, Mayer L, eds. Mucosal Immunology, 3rd edn. Burlington, San Diego, London: Elsevier-Academic Press, 2005; 667-680.